← Browse by Condition
Medical Condition
unresectable biliary tract carcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2
NCT07062263 Phase 3
Recruiting
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
Enrollment
220 pts
Location
India
Sponsor
Tata Memorial Centre
NCT06135896 Phase 2
Recruiting
Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers
Enrollment
98 pts
Location
South Korea
Sponsor
National Cancer Center, Korea
NCT06749730 Phase 2
Recruiting
Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma
Enrollment
63 pts
Location
China
Sponsor
Henan Cancer Hospital